A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels

Psycho-Oncology

Volumn 24, Issue 3, 2015, Pages 348-354

  Venderbos, Lionne D F ^a   Van Den Bergh, Roderick C N ^a   Roobol, Monique J ^a   Schröder, Fritz H ^a   Essink Bot, Marie Louise ^a,b   Bangma, Chris H ^a   Steyerberg, Ewout W ^a   Korfage, Ida J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE SURVEILLANCE; ADULT; AGED; ANXIETY; ANXIETY ASSESSMENT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CLINICAL TRIAL; DECISIONAL CONFLICT SCALE; DISTRESS SYNDROME; EXTERNAL BEAM RADIOTHERAPY; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEMORIAL ANXIETY SCALE FOR PROSTATE CANCER; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; QUALITY OF LIFE INDEX; SHORT FORM 12; STATE TRAIT ANXIETY INVENTORY; COMPLICATION; DECISION MAKING; DEPRESSION; DISEASE COURSE; ETIOLOGY; FEAR; HEALTH SURVEY; MENTAL STRESS; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDY; PROSTATIC NEOPLASMS; PSYCHOLOGY; QUESTIONNAIRE; RISK ASSESSMENT; WATCHFUL WAITING;

ANXIETY; DECISION MAKING; DEPRESSION; DISEASE PROGRESSION; FEAR; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NETHERLANDS; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RISK ASSESSMENT; STRESS, PSYCHOLOGICAL; WATCHFUL WAITING;

EID: 84929302920     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.3657     Document Type: Article

References (34)

1. Glass AS, Cooperberg MR, Meng MV, Carroll PR. Role of active surveillance in the management of localized prostate cancer. J Natl Cancer Inst Monogr 2012;2012 (45):202-206.
2. van den Bergh RC, Essink-Bot ML, Roobol MJ, et al. Anxiety and distress during active surveillance for early prostate cancer. Cancer 2009;115(17):3868-3878.
3. Center MM, Jemal A, Lortet-Tieulent J, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol 2012;61(6):1079-1092.
4. Carroll PR AY, Cooperberg MR, et al. Treatment of low-and intermediate-risk prostate cancer: definition, treatment options and outcomes of care, Andriole G, Wirth M (eds.), In Prostate Cancer-an International Consultation of Prostate Cancer. Societe Internationale d'Urologie: Canada, 2012; 329-362.
5. Bellardita L, Graffigna G, Donegani S, et al. Patient's choice of observational strategy for early-stage prostate cancer. Neuropsychol Trends 2012;12:107-116.
6. van den Bergh RC, Korfage IJ, Bangma CH. Psychological aspects of active surveillance. Curr Opin Urol 2012;22(3):237-242.
7. Bellardita L, Rancati T, Alvisi MF, et al. Predictors of health-related quality of life and adjustment to prostate cancer during active surveillance. Eur Urol 2013;64(1):30-36.
8. van den Bergh RC, Essink-Bot ML, Roobol MJ, Schroder FH, Bangma CH, Steyerberg EW. Do anxiety and distress increase during active surveillance for low risk prostate cancer? J Urol 2010;183(5):1786-1791.
9. WallaceM.Uncertainty and quality of life of older men who undergo watchful waiting for prostate cancer. Oncol Nurs Forum 2003;30(2):303-309.
10. Clark JA, Inui TS, Silliman RA, et al. Patients' perceptions of quality of life after treatment for early prostate cancer. J Clin Oncol 2003;21(20):3777-3784.
11. Bul M, Zhu X, Valdagni R, et al. Active surveillance for low-risk prostate cancer worldwide: the PRIAS study. Eur Urol 2013;63(4):597-603.
12. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. PLoS Med 2007;4(10):1628-1654.
13. American Cancer Society. www.cancer.org [accessed 12 December 2013].
14. O'Conner A. Validation of a Decisional Conflict Scale. Med Decis Making 1995; 51:25-30.
15. Decisional Conflict Scale-user manual. 2006. Ottowa Health Decision Centre at the Ottowa Health Research Institute (University of Ottowa). Available from: http://www.ohri. ca/decision-aid [accessed January 2011].
16. Schroevers MJ, Sanderman R, van Sonderen E, Ranchor AV. The evaluation of the Center for Epidemiologic Studies Depression (CESD) scale: depressed and positive affect in cancer patients and healthy reference subjects. Qual Life Res 2000;9(9):1015-1029.
17. Radloff L. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1(3):385-401.
18. Kruijshaar ME, Siersema PD, Janssens AC, et al. Patients with Barrett's esophagus perceive their risk of developing esophageal adenocarcinoma as low. Gastrointest Endosc 2007;65(1):26-30.
19. Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol 1992;31 (Pt 3):301-306.
20. Millar K, Jelicic M, Bonke B, Asbury AJ. Assessment of preoperative anxiety: comparison of measures in patients awaiting surgery for breast cancer. Br J Anaesth 1995; 74(2):180-183.
21. Roth AJ, Rosenfeld B, Kornblith AB, et al. The Memorial Anxiety Scale for Prostate Cancer: validation of a new scale to measure anxiety in men with prostate cancer. Cancer 2003;97(11):2910-2918.
22. Roth A, Nelson CJ, Rosenfeld B, et al. Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC). Psychosomatics 2006;47 (4):340-347.
23. Ware J, Jr., Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34(3):220-233.
24. Koedoot N,Molenaar S, Oosterveld P, et al. The Decisional Conflict Scale: further validation in two samples of Dutch oncology patients. Patient Educ Couns 2001;45(3):187-193.
25. Beekman AT, van Limbeek J, Deeg DJ, Wouters L, van Tilburg W. A screening tool for depression in the elderly in the general population: the usefulness of Center for Epidemiological Studies Depression Scale (CES-D)] Een screeningsinstrument voor depressie bij ouderen in de algemene bevolking: de bruikbaarheid van de Center for Epidemiologic Studies Depression Scale (CES-D). Tijdschr Gerontol Geriatr 1994;25(3):95-103.
26. van der Bij AK, de Weerd S, Cikot RJ, Steegers EA, Braspenning JC. Validation of the Dutch short form of the state scale of the Spielberger State-Trait Anxiety Inventory: considerations for usage in screening outcomes. Community Genet 2003;6(2):84-87.
27. Razavi D, Gandek B. Testing Dutch and French translations of the SF-36 Health Survey among Belgian angina patients. J Clin Epidemiol 1998;51(11):975-981.
28. van den Bergh RC, Korfage IJ, Borsboom GJ, Steyerberg EW, Essink-Bot ML. Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the Memorial Anxiety Scale for Prostate Cancer. Qual Life Res 2009;18(8):1061-1066.
29. Roberts RE, Vernon SW. The Center for Epidemiologic Studies Depression Scale: its use in a community sample. Am J Psychiatry 1983;140(1):41-46.
30. Norman GR, Sloan JA,WyrwichKW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation.Med Care 2003;41(5):582-592.
31. Klotz L. Active surveillance, quality of life, and cancer-related anxiety. Eur Urol 2013;64(1):37-39.
32. Vasarainen H, Lokman U, Ruutu M, Taari K, Rannikko A. Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial. BJU Int 2012;109(11):1614-1619.
33. Lokman U, Vasarainen H, Lahdensuo K, et al. Prostate cancer active surveillance: health-related quality of life in the Finnish arm of the prospective PRIAS-study. Three year update. Eur Urol Suppl 2013;12;e274.
34. Goh AC, Kowalkowski MA, Bailey DE, Jr., Kazer MW, Knight SJ, Latini DM. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance. BJU Int 2012;110(2 Pt 2):E50-E56.